Viewpoint: Trump Administration should cut funding to WHO’s IARC cancer agency

IARC x
Credit: IARC
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

The World Health Organization’s International Agency for Research on Cancer] IARC is supposed to be a scientific program that classifies chemicals according to carcinogenic risks, but its process has proven highly flawed and susceptible to political, rather than merely scientific concerns. IARC’s faulty conclusions can create serious problems, including bans on useful products, market deselection of such products, and public confusion about cancer risks.

IARC receives funding from member states and has a two-year budget. During 2018-2019 IARC reports a budget of €44.1 million (near $50 million in 2020 dollars), of which the United States was assessed to pay more than €3.3 million (almost $3.6 million in 2020 dollars).

The 2015 classification of the weed killer glyphosate as “probably carcinogenic to humans” offers an egregious example of a classification tainted by political agendas. This classification—in addition to being only a meaningless hazard assessment—is out of line with nearly every other assessment conducted by regulatory bodies and academic researchers around the world.

Related article:  EU approves imports of three new GMO soybean varieties for animal feeds

The International Agency for Research on Cancer’s classification scheme is fatally flawed and incapable of providing meaningful information for policy makers or consumers. Worse, its increasingly political nature indicates that reform is unlikely to solve these problems. It makes no sense for U.S. taxpayers to fund IARC. Pulling funding would be a helpful message to the world that IARC’s nonsensical classifications should be disregarded.

Read the original post

Share via
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend